S100A8 and S100A9 can promote mucus hypersecretion typical of asthma in BECs, which is consistent with our previously published works documenting reduced MUC5AC post-BT along with IL-13+ cells in bronchial biopsies collected from a similar cohort [21, 43]. Here, S100A9 is linked to asthma.